e 5880 has been researched along with Hemorrhage, Subarachnoid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Hori, T; Kasuya, H; Suzuki, S; Yamanishi, Y | 1 |
| Endo, S; Hirashima, Y; Kato, R; Takaku, A | 1 |
| Endo, S; Hirashima, Y; Kobayashi, N; Nukui, H; Takaku, A | 1 |
1 trial(s) available for e 5880 and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety.
Topics: Adult; Aged; Aneurysm, Ruptured; Brain; Clinical Protocols; Dose-Response Relationship, Drug; Female; Humans; Incidence; Injections, Intravenous; Intracranial Aneurysm; Male; Middle Aged; Piperidines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Radiography; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracranial | 2001 |
2 other study(ies) available for e 5880 and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Effect of a platelet-activating factor antagonist, E5880, on cerebrovasospasm following subarachnoid hemorrhage in a canine double-hemorrhage model.
Topics: Animals; Basilar Artery; Cerebrovascular Circulation; Disease Models, Animal; Dogs; Female; Male; Piperidines; Platelet Activating Factor; Pyridinium Compounds; Subarachnoid Hemorrhage; Time Factors; Vasoconstriction; Vasospasm, Intracranial | 2002 |
Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880.
Topics: Animals; Female; Ischemic Attack, Transient; Piperidines; Pyridinium Compounds; Rabbits; Subarachnoid Hemorrhage; Thromboxane B2 | 1996 |